Fluorine in PDB 7ue1: Hiv-1 Integrase Catalytic Core Domain Mutant (Kgd) in Complex with Inhibitor Grl-142
Protein crystallography data
The structure of Hiv-1 Integrase Catalytic Core Domain Mutant (Kgd) in Complex with Inhibitor Grl-142, PDB code: 7ue1
was solved by
M.Aoki,
H.Aoki-Ogata,
H.Bulut,
H.Hayashi,
D.Davis,
K.Hasegawa,
R.Yarchoan,
A.K.Ghosh,
A.K.Pau,
H.Mitsuya,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
86.49 /
3.00
|
Space group
|
I 4 2 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
111.368,
111.368,
137.288,
90,
90,
90
|
R / Rfree (%)
|
22.3 /
31.7
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Hiv-1 Integrase Catalytic Core Domain Mutant (Kgd) in Complex with Inhibitor Grl-142
(pdb code 7ue1). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 2 binding sites of Fluorine where determined in the
Hiv-1 Integrase Catalytic Core Domain Mutant (Kgd) in Complex with Inhibitor Grl-142, PDB code: 7ue1:
Jump to Fluorine binding site number:
1;
2;
Fluorine binding site 1 out
of 2 in 7ue1
Go back to
Fluorine Binding Sites List in 7ue1
Fluorine binding site 1 out
of 2 in the Hiv-1 Integrase Catalytic Core Domain Mutant (Kgd) in Complex with Inhibitor Grl-142
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Hiv-1 Integrase Catalytic Core Domain Mutant (Kgd) in Complex with Inhibitor Grl-142 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F301
b:105.6
occ:1.00
|
F1
|
B:7OA301
|
0.0
|
105.6
|
1.0
|
C33
|
B:7OA301
|
1.4
|
99.2
|
1.0
|
HD1
|
B:TYR99
|
2.3
|
105.8
|
1.0
|
C06
|
B:7OA301
|
2.4
|
101.4
|
1.0
|
C35
|
B:7OA301
|
2.4
|
95.3
|
1.0
|
HB2
|
B:TYR99
|
2.5
|
80.2
|
1.0
|
H1
|
B:7OA301
|
2.6
|
122.0
|
1.0
|
H25
|
B:7OA301
|
2.6
|
114.6
|
1.0
|
HG22
|
A:THR174
|
2.7
|
101.1
|
1.0
|
HG23
|
A:THR174
|
2.9
|
101.1
|
1.0
|
HG21
|
A:THR174
|
2.9
|
101.1
|
1.0
|
CG2
|
A:THR174
|
3.0
|
84.0
|
1.0
|
CD1
|
B:TYR99
|
3.3
|
88.0
|
1.0
|
CB
|
B:TYR99
|
3.4
|
66.6
|
1.0
|
HA
|
B:TYR99
|
3.5
|
81.0
|
1.0
|
C07
|
B:7OA301
|
3.6
|
95.6
|
1.0
|
C34
|
B:7OA301
|
3.6
|
96.2
|
1.0
|
O
|
B:GLN95
|
3.7
|
104.8
|
1.0
|
H
|
B:TYR99
|
3.8
|
98.8
|
1.0
|
CG
|
B:TYR99
|
3.8
|
78.1
|
1.0
|
HB3
|
B:GLN95
|
3.8
|
181.5
|
1.0
|
CA
|
B:TYR99
|
3.8
|
67.3
|
1.0
|
N
|
B:TYR99
|
4.0
|
82.1
|
1.0
|
C08
|
B:7OA301
|
4.1
|
94.3
|
1.0
|
HB3
|
B:ALA98
|
4.2
|
107.2
|
1.0
|
HB3
|
B:TYR99
|
4.2
|
80.2
|
1.0
|
CE1
|
B:TYR99
|
4.4
|
99.5
|
1.0
|
C
|
B:GLN95
|
4.5
|
115.0
|
1.0
|
CB
|
A:THR174
|
4.5
|
90.5
|
1.0
|
HA
|
B:GLN95
|
4.5
|
154.5
|
1.0
|
HE1
|
B:TYR99
|
4.5
|
119.6
|
1.0
|
HZ1
|
A:LYS173
|
4.6
|
124.6
|
1.0
|
HE2
|
A:LYS173
|
4.6
|
123.0
|
1.0
|
CB
|
B:GLN95
|
4.8
|
151.0
|
1.0
|
F2
|
B:7OA301
|
4.8
|
98.7
|
1.0
|
CA
|
B:GLN95
|
4.8
|
128.6
|
1.0
|
H24
|
B:7OA301
|
4.8
|
125.8
|
1.0
|
OE1
|
B:GLN95
|
4.8
|
119.7
|
1.0
|
HE3
|
A:LYS173
|
4.9
|
123.0
|
1.0
|
HA
|
A:THR174
|
4.9
|
113.8
|
1.0
|
C32
|
B:7OA301
|
4.9
|
104.7
|
1.0
|
HB
|
A:THR174
|
4.9
|
108.9
|
1.0
|
HD23
|
B:LEU102
|
4.9
|
92.5
|
1.0
|
C
|
B:ALA98
|
4.9
|
89.9
|
1.0
|
|
Fluorine binding site 2 out
of 2 in 7ue1
Go back to
Fluorine Binding Sites List in 7ue1
Fluorine binding site 2 out
of 2 in the Hiv-1 Integrase Catalytic Core Domain Mutant (Kgd) in Complex with Inhibitor Grl-142
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Hiv-1 Integrase Catalytic Core Domain Mutant (Kgd) in Complex with Inhibitor Grl-142 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F301
b:98.7
occ:1.00
|
F2
|
B:7OA301
|
0.0
|
98.7
|
1.0
|
C34
|
B:7OA301
|
1.4
|
96.2
|
1.0
|
C35
|
B:7OA301
|
2.4
|
95.3
|
1.0
|
C08
|
B:7OA301
|
2.4
|
94.3
|
1.0
|
HB2
|
B:ALA129
|
2.6
|
102.2
|
1.0
|
H25
|
B:7OA301
|
2.6
|
114.6
|
1.0
|
H2
|
B:7OA301
|
2.6
|
113.5
|
1.0
|
HB1
|
B:ALA98
|
2.7
|
107.2
|
1.0
|
HB1
|
B:ALA129
|
2.9
|
102.2
|
1.0
|
HB2
|
B:LEU102
|
3.0
|
90.8
|
1.0
|
HD22
|
B:LEU102
|
3.2
|
92.5
|
1.0
|
CB
|
B:ALA129
|
3.2
|
84.9
|
1.0
|
O1
|
B:7OA301
|
3.2
|
85.1
|
1.0
|
HB3
|
B:ALA98
|
3.4
|
107.2
|
1.0
|
CB
|
B:ALA98
|
3.5
|
89.2
|
1.0
|
C33
|
B:7OA301
|
3.6
|
99.2
|
1.0
|
C07
|
B:7OA301
|
3.6
|
95.6
|
1.0
|
HA
|
B:ALA129
|
3.7
|
90.7
|
1.0
|
O
|
B:ALA98
|
3.7
|
86.7
|
1.0
|
C
|
B:ALA98
|
3.9
|
89.9
|
1.0
|
CA
|
B:ALA129
|
4.0
|
75.4
|
1.0
|
HD13
|
B:LEU102
|
4.0
|
95.0
|
1.0
|
CD2
|
B:LEU102
|
4.1
|
76.9
|
1.0
|
CB
|
B:LEU102
|
4.1
|
75.5
|
1.0
|
HB3
|
B:ALA129
|
4.1
|
102.2
|
1.0
|
C06
|
B:7OA301
|
4.1
|
101.4
|
1.0
|
CA
|
B:ALA98
|
4.2
|
92.1
|
1.0
|
HD23
|
B:LEU102
|
4.2
|
92.5
|
1.0
|
HA
|
B:TYR99
|
4.2
|
81.0
|
1.0
|
O
|
B:ALA125
|
4.3
|
80.0
|
1.0
|
H
|
B:ALA129
|
4.3
|
93.5
|
1.0
|
C7
|
B:7OA301
|
4.4
|
83.7
|
1.0
|
N
|
B:TYR99
|
4.4
|
82.1
|
1.0
|
HB2
|
B:ALA98
|
4.4
|
107.2
|
1.0
|
HB3
|
B:LEU102
|
4.4
|
90.8
|
1.0
|
H33
|
B:7OA301
|
4.4
|
100.7
|
1.0
|
HA
|
B:ALA98
|
4.5
|
110.8
|
1.0
|
N
|
B:ALA129
|
4.5
|
77.7
|
1.0
|
CG
|
B:LEU102
|
4.5
|
78.6
|
1.0
|
HB1
|
B:ALA125
|
4.5
|
108.0
|
1.0
|
O2
|
B:7OA301
|
4.5
|
76.7
|
1.0
|
H19
|
B:7OA301
|
4.6
|
117.3
|
1.0
|
C8
|
B:7OA301
|
4.6
|
95.8
|
1.0
|
H35
|
B:7OA301
|
4.6
|
115.2
|
1.0
|
H
|
B:LEU102
|
4.6
|
93.1
|
1.0
|
HG22
|
A:THR174
|
4.6
|
101.1
|
1.0
|
CD1
|
B:LEU102
|
4.7
|
78.9
|
1.0
|
F1
|
B:7OA301
|
4.8
|
105.6
|
1.0
|
HG21
|
A:THR174
|
4.8
|
101.1
|
1.0
|
CA
|
B:TYR99
|
4.9
|
67.3
|
1.0
|
H36
|
B:7OA301
|
4.9
|
115.2
|
1.0
|
H
|
B:TYR99
|
4.9
|
98.8
|
1.0
|
HD21
|
B:LEU102
|
4.9
|
92.5
|
1.0
|
C32
|
B:7OA301
|
4.9
|
104.7
|
1.0
|
O23
|
B:7OA301
|
5.0
|
84.0
|
1.0
|
HB3
|
B:ALA128
|
5.0
|
83.1
|
1.0
|
|
Reference:
H.Bulut,
H.Hayashi,
K.Hasegawa,
K.Murayama,
M.Aoki,
H.Mitsuya.
Hiv-1-Nls-Targeting Grl-142 Exerts Potent Activity Against Insti-Resistant Hiv-1 To Be Published.
Page generated: Fri Aug 2 14:06:13 2024
|